Submucous Resection (SMR) for Nasal Septal Deviation — Cost, Top Hospitals & Success Rates | MyMedicPlus

Submucous resection (SMR) is a surgical procedure performed by otolaryngologists (ENT surgeons) to correct a deviated nasal septum — a displacement of the cartilaginous and/or bony wall that divides the nasal cavity into left and right chambers. The nasal septum is composed of the quadrilateral cartilage anteriorly, the perpendicular plate of the ethmoid and vomer posteriorly, and the maxillary and palatine crest inferiorly. Deviation of any of these components — whether congenital, developmental, or the result of nasal trauma — can impair nasal airflow, promote turbulent air passage, and produce chronic nasal obstruction, mouth breathing, snoring, recurrent sinusitis, and impaired sense of smell.

SMR was first described and popularised by Killian (1904) and Freer (1902) as the Killian-Freer operation, sometimes simply called Killian's operation. The classical technique involves elevating the mucoperichondrial and mucoperiosteal flaps on both sides of the septum, resecting the deviated cartilage and/or bone beneath, and replacing the flaps. Because the mucosal lining is preserved (hence 'submucous'), the structural integrity of the septum is maintained while the obstructing framework is removed.

Over the past three decades, the endoscopic septoplasty technique — which uses a nasal endoscope for direct visualisation rather than the traditional headlight and nasal speculum — has largely superseded classical SMR in centres with advanced ENT equipment, offering superior lighting, magnified views, and more targeted cartilage resection with better preservation of normal tissue. However, classical SMR remains widely performed, particularly in resource-limited settings, and is a valid and effective operation for most indications when performed by an experienced surgeon.

SMR is often combined with turbinate reduction procedures (inferior turbinoplasty or submucous diathermy of the inferior turbinate) to address any compensatory turbinate hypertrophy on the wider nasal passage, and with functional endoscopic sinus surgery (FESS) when chronic sinusitis is a co-existing problem.

SMR addresses structural nasal pathology arising from septal deviation and its downstream consequences:

• Deviated nasal septum (DNS) with nasal obstruction: The primary indication. Patients typically complain of unilateral or bilateral nasal blockage, worsened by upper respiratory infections. Nasal obstruction may be positional (worse on the side of the deviation when lying down) or constant. Significant deviation producing ≥60% reduction in cross-sectional area on nasal endoscopy or acoustic rhinometry typically warrants surgical correction.
• Chronic mouth breathing: Persistent nasal obstruction forces patients to breathe through the mouth, resulting in dry mouth, halitosis, disrupted sleep, and, in children, craniofacial growth abnormalities. SMR restoring nasal patency allows reversion to nasal breathing.
• Snoring and obstructive sleep apnoea (OSA) related to nasal obstruction: Nasal septoplasty is frequently performed as part of the surgical management of snoring and mild OSA, typically alongside soft palate surgery (uvulopalatopharyngoplasty, UPPP) or mandibular advancement.
• Recurrent acute sinusitis and chronic rhinosinusitis: A severely deviated septum can obstruct the ostiomeatal complex, impeding mucociliary drainage from the paranasal sinuses. SMR, often combined with FESS, improves sinus ventilation and reduces sinusitis frequency.
• Epistaxis (nosebleeds) from prominent spur: A sharp bony or cartilaginous septal spur on the convex side of a deviation can abrade the nasal mucosa, causing recurrent nosebleeds that respond poorly to medical management. Removal of the spur during SMR/septoplasty resolves this.
• Anosmia or hyposmia: Turbulent or obstructed nasal airflow can reduce odorant delivery to the olfactory epithelium; restoration of nasal patency may improve smell sensation, though central olfactory causes must be excluded first.

Careful pre-operative evaluation ensures that the proposed septoplasty or SMR will address the patient's symptoms and that surgical risks are acceptable.

Indications for surgery (typically, all three should be present):

1. Documented symptomatic nasal obstruction on the side of the major deviation, causing significant impairment of quality of life
2. Failure of adequate medical management (topical nasal corticosteroids for ≥3 months, saline irrigations, and antihistamines if allergic rhinitis co-exists)
3. Endoscopic or radiological confirmation of clinically significant septal deviation contributing to obstruction

Pre-operative workup:

• Anterior rhinoscopy and nasal endoscopy: Provides direct visualisation of the septum, turbinates, and posterior nasal cavity. Performed with and without vasoconstrictors (xylometazoline/oxymetazoline) to distinguish fixed structural obstruction from mucosal engorgement responsive to decongestion.
• CT sinuses (if FESS is planned): Coronal and axial CT identifies the pattern of septal deviation, bony spurs, adjacent turbinate anatomy, and any sinus disease requiring concomitant management.
• Allergy testing: Coexisting allergic rhinitis should be identified and managed peri-operatively, as uncontrolled allergy will cause turbinate swelling that reduces the benefit of septoplasty.
• Paediatric considerations: SMR is generally deferred until nasal skeletal growth is complete (typically 16–18 years in females, 17–19 years in males) to avoid disrupting septal growth centres. Limited conservative approaches are used in severe paediatric cases.
• Anaesthetic assessment: SMR can be performed under general anaesthesia or, less commonly, local anaesthesia with sedation. Pre-operative assessment includes standard blood tests, assessment of any anticoagulant use, and discussion of anaesthetic preference.

Two principal techniques are used for surgical correction of nasal septal deviation, with several institutional variations and adjunctive procedures commonly combined.

Classical Submucous Resection (Killian's Technique):

1. Anaesthesia and decongestion: General anaesthesia is standard. Cocaine solution (4–10%) or adrenaline-soaked pledgets are applied to the nasal mucosa to achieve vasoconstriction and topical anaesthesia, reducing intra-operative bleeding.
2. Incision: A Killian's incision (hemitransfixion incision) is made through the mucoperichondrium on the concave (non-deviated) side, approximately 1 cm posterior to the columella.
3. Flap elevation: A Freer or Cottle elevator is used to raise a mucoperichondrial flap on one side, then — after carefully creating a window through the cartilage — a mucoperiosteal flap on the contralateral side. Bilateral flaps must be preserved intact to prevent septal perforation.
4. Resection of deviated cartilage and bone: The deviated quadrilateral cartilage, perpendicular plate, vomer, or bony spur is resected using Tilley-Henkel forceps, a Kerrison punch, or a chisel, leaving a 1 cm dorsal and caudal cartilage strut (the 'L-strut') to maintain nasal tip support.
5. Replacement of flaps and closure: Mucosal flaps are replaced in the midline and the incision is closed with absorbable sutures. Nasal packs (non-adherent ribbon gauze or pneumatic splints) and/or trans-septal quilting sutures are placed to obliterate the dead space and prevent haematoma.

Endoscopic Septoplasty: Uses a 4 mm 0° or 30° nasal endoscope. Provides magnified, well-illuminated views of the nasal anatomy, allowing more targeted resection with preservation of normal cartilage. The technique follows similar anatomical principles but allows identification of posterior deviations and bony spurs that may be missed with the classical approach. Increasingly preferred in centres with endoscopic ENT expertise.

Adjunctive procedures frequently combined with SMR/septoplasty:

• Inferior turbinoplasty / submucosal diathermy: Reduces compensatory hypertrophy of the inferior turbinate on the wider (non-deviated) side, improving overall nasal airflow
• Functional endoscopic sinus surgery (FESS): Opens obstructed sinus drainage pathways when chronic sinusitis co-exists
• Rhinoplasty (functional or cosmetic): Addresses external nasal deformity (deviated nose, saddle nose) when present

SMR and septoplasty provide significant symptomatic benefit to appropriately selected patients, with high rates of subjective improvement in nasal obstruction.

Nasal airflow improvement: Objective measurements of nasal airway patency using acoustic rhinometry and anterior rhinomanometry consistently demonstrate significant improvement in cross-sectional area and airflow after septoplasty. Studies report 70–85% of patients experiencing subjectively meaningful improvement in nasal breathing at 6–12 months post-operatively.

Quality of life: Validated disease-specific instruments including the Nasal Obstruction Symptom Evaluation (NOSE) scale and the Sinonasal Outcome Test 22 (SNOT-22) show consistent and clinically significant improvements after septoplasty, often with effects maintained at 5-year follow-up.

Sleep quality: Restoration of nasal patency reduces snoring and improves polysomnographic parameters in patients with nasal obstruction-related sleep disturbance. The combination of septoplasty with turbinate reduction reduces CPAP pressure requirements in OSA patients who undergo septoplasty as part of multi-level airway surgery.

Reduction in sinusitis: Patients with recurrent acute sinusitis related to ostiomeatal complex obstruction from a deviated septum experience a reduction in sinusitis episodes after septoplasty ± FESS. The magnitude of benefit is greatest in those with documented anatomical drainage impairment on pre-operative CT.

Minimally invasive and generally safe: SMR and endoscopic septoplasty are well-established, low-risk procedures with negligible mortality. Recovery is faster than many other ENT operations, and the procedure does not alter the external appearance of the nose (unless combined with rhinoplasty).

SMR/septoplasty is generally safe but carries procedure-specific risks that patients must understand before consenting to surgery.

Common and generally minor complications:

• Post-operative nasal bleeding (epistaxis): Occurs in 1–3% of cases; most settle with nasal packing; rarely requires return to theatre for cauterisation or re-packing.
• Post-operative nasal crusting and congestion: Nasal crusting and a blocked sensation for 2–6 weeks post-operatively are nearly universal; resolve with saline irrigation and nasal moisturisers.
• Nasal packs discomfort: Traditional ribbon gauze packs are uncomfortable; most surgeons now use dissolvable haemostatic materials or silastic splints instead.
• Transient hyposmia: Reduced sense of smell immediately post-operatively, typically resolving within 2–4 weeks as post-operative oedema subsides.

Less common but significant complications:

• Septal haematoma: Occurs in ≤1% of cases; if unrecognised, blood accumulates between the flaps, creates a pressure necrosis of the cartilage, and can result in septal perforation or saddle nose deformity. Prevented by adequate packing or quilting sutures; treated by immediate evacuation and repackaging.
• Septal perforation: A hole through the nasal septum, occurring in 1–3% of SMR cases (higher than endoscopic septoplasty). Causes paradoxical nasal obstruction, crusting, bleeding, and a 'whistling' sound with breathing. Small perforations may be managed conservatively; symptomatic large perforations require surgical repair with local or composite flaps, which is technically challenging.
• Saddle nose deformity: If too much dorsal or caudal cartilage is resected (violating the 'L-strut' principle), the nasal bridge may collapse, creating a characteristic saddled appearance requiring reconstructive rhinoplasty. This is a risk more associated with classical SMR (which resects more cartilage) than endoscopic septoplasty.
• Persistent or worsened nasal obstruction: Residual deviation, turbinate hypertrophy not addressed at surgery, or postoperative adhesions (synechiae) between the septum and lateral nasal wall can result in incomplete or failed symptom relief in 10–15% of patients, occasionally requiring revision surgery.
• Intracranial complications: Extremely rare (<0.1%) but serious; inadvertent violation of the cribriform plate can cause CSF rhinorrhoea or intracranial infection. Risk is essentially confined to endoscopic procedures in the posterior nasal cavity.

Recovery after SMR/septoplasty follows a predictable course, with most patients returning to normal activities within 1–2 weeks.

Immediate post-operative period (Day 0–2): The procedure is typically performed as a day-case or with one overnight admission. After extubation, patients recover in a post-anaesthesia care unit. Nasal packs (if used) may remain for 24–48 hours; their removal is uncomfortable but brief. Oral analgesics (paracetamol, NSAIDs) manage post-operative pain, which is mild to moderate for most patients. An oral or topical decongestant (xylometazoline) may be prescribed short-term. Patients should not blow their nose forcefully for 2 weeks to avoid disturbing healing mucosal flaps.

First two weeks: Nasal congestion, crusting, and a reduced sense of smell are expected as post-operative oedema peaks at 48–72 hours and gradually subsides. Twice-daily saline nasal irrigations (using a Neti pot or squeeze bottle, e.g., NeilMed SinuRinse) are the single most important post-operative care measure — they soften crusts, prevent adhesion formation, and promote mucociliary clearance. A nasal steroid spray is prescribed from Day 7 onwards to reduce mucosal inflammation and prevent polyp recurrence in at-risk patients.

First clinic review (Day 7–14): The surgeon inspects the post-operative nasal cavity, removes any crusts under direct vision, checks for adhesion formation, and assesses early healing. If internal splints were placed, they are removed at this visit.

4–6 week review: The nose is typically 80–90% clear of congestion and the patient's breathing substantially improved. Final scar maturation and resolution of residual mucosal oedema continue for 3–6 months; patients should be counselled not to judge the final outcome prematurely. Physical exercise, contact sports, and heavy lifting should be avoided for 3–4 weeks. Air travel after SMR is generally safe once pack removal is confirmed and swelling has subsided, typically 5–7 days post-operatively.

SMR and septoplasty are among the most commonly performed elective ENT procedures worldwide, and costs vary considerably by country, technique (classical vs. endoscopic), concomitant procedures, and type of facility.

Estimated costs by region:

• United States: USD 4,000–12,000 (facility + surgeon + anaesthesiologist; endoscopic septoplasty alone); USD 8,000–20,000 when combined with turbinate reduction and FESS; insurance coverage is variable for septoplasty (usually covered if documented functional impairment)
• United Kingdom (NHS): Available on the NHS for functional nasal obstruction; private pricing GBP 2,000–5,000 for septoplasty alone
• India: INR 30,000–80,000 (USD 360–960) at private hospitals; USD 1,200–2,500 for endoscopic septoplasty with turbinate reduction at a leading ENT centre
• Thailand: USD 1,500–3,500 for septoplasty ± turbinoplasty at JCI-accredited hospitals
• Turkey: USD 1,200–3,000 including surgeon, anaesthesia, and one-night admission; Turkey is particularly popular for combined septoplasty and cosmetic rhinoplasty
• Singapore: SGD 5,000–12,000 (USD 3,700–9,000) at private specialist ENT centres

Key cost drivers:

• Concomitant procedures: Each additional procedure (turbinoplasty, FESS, rhinoplasty) adds substantially to the total cost; combined septorhinoplasty (functional + cosmetic) can cost USD 15,000–35,000 in the US
• Technique: Endoscopic septoplasty requires more expensive operating theatre equipment (endoscope, camera, shaver systems) but is associated with shorter recovery and lower complication rates; this is usually reflected in slightly higher surgeon fees
• Anaesthesia type: General anaesthesia adds anaesthesiologist fees; local anaesthesia with sedation is cheaper but less commonly used for septoplasty
• Post-operative splints and implants: Silastic nasal splints (USD 50–150 each) are an additional consumable cost in some centres

Before recommending surgery for nasal septal deviation, non-surgical management should be optimised. For patients who are surgical candidates, alternative surgical techniques offer different trade-offs.

Medical management (first-line):

• Topical nasal corticosteroids: Fluticasone propionate, mometasone, or budesonide sprays reduce mucosal inflammation and compensatory turbinate hypertrophy. They do not correct structural deviation but can improve overall nasal patency significantly (average 20–30% improvement in airflow) and should be tried for at least 3 months before surgery is considered.
• Nasal decongestants: Topical xylometazoline or oxymetazoline provides rapid but temporary relief; chronic use (>5–7 days) causes rhinitis medicamentosa (rebound congestion) and is contraindicated for long-term use.
• Saline nasal irrigation: Reduces mucosal congestion, removes crusts, and improves mucociliary clearance; a safe daily maintenance therapy.
• Allergy management: Allergen avoidance, antihistamines, and allergen immunotherapy (desensitisation) for allergic rhinitis patients reduce mucosal swelling and may reduce subjective obstruction significantly, even if the structural deviation is unchanged.

Surgical alternatives to classical SMR:

• Endoscopic septoplasty: The modern gold-standard alternative to classical SMR. Uses an endoscope for superior visualisation, more targeted resection, and better conservation of septal cartilage. Associated with lower rates of septal perforation and saddle nose deformity compared to classical SMR. Now the preferred technique at most tertiary ENT centres. Outcomes for nasal airflow improvement are equivalent or superior to classical SMR.
• Extracorporeal septoplasty: The septum is removed, straightened on the surgical bench, and reimplanted. Used for severe, complex C- or S-shaped deviations that cannot be adequately corrected in situ. Technically demanding; risk of septal perforation and saddle nose is higher than standard septoplasty.
• Septorhinoplasty: Combines internal septoplasty with external rhinoplasty to simultaneously correct internal deviation and external nasal deformity. Appropriate when both functional and cosmetic correction are desired.
• Inferior turbinate reduction alone: When obstruction is predominantly from turbinate hypertrophy on the wider (non-deviated) side rather than the deviation itself, targeted turbinate reduction (radiofrequency ablation, microdebrider turbinoplasty, or submucosal diathermy) may address symptoms without formal septoplasty. Radiofrequency turbinoplasty (e.g., the Coblation technique) can be performed under local anaesthesia in an outpatient setting.